What is Leerink Partnrs’ Estimate for ACHC FY2024 Earnings?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Acadia Healthcare in a research note issued to investors on Friday, November 1st. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $3.42 per share for the year, down from their previous estimate of $3.50. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.97 EPS and Q3 2025 earnings at $0.95 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year.

A number of other brokerages also recently commented on ACHC. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $86.67.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $42.51 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business’s 50 day moving average price is $65.00 and its 200 day moving average price is $67.55. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 13.94, a PEG ratio of 1.33 and a beta of 1.33. Acadia Healthcare has a one year low of $41.42 and a one year high of $87.77.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. Blue Trust Inc. raised its stake in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in Acadia Healthcare in the second quarter worth $59,000. Covestor Ltd lifted its holdings in Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after acquiring an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the 3rd quarter worth $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.